W. McNicholas (Dublin, Ireland), M. Bonsignore (Palermo, Italy)
Predictors of elevated tumour necrosis factor alpha level in obstructive sleep apnoea syndrome
S. Ryan, C. T. Taylor, W. T. McNicholas (Dublin, Ireland)
|   |
The effect of continuous positive airway pressure on glucose excursions in diabetics with sleep-disordered breathing: the results of continuous glucose monitoring
M. Pallayova, V. Donic, V. Donicova, Z. Tomori, S. Gresova (Kosice, Slovakia)
| |
Elevated leptin is associated with impaired glucose tolerance in obstructive sleep apnoea (OSA)
I. Papaioannou, M. Patterson, G. Twigg, A. K. Simonds, M. Ghatei, M. J. Morrell, M. I. Polkey (London, United Kingdom)
| |
Frequency of distribution of IL-1, IL-6 and TNFa gene polymorphism in patients with obstructive sleep apnea syndrome (OSAS)
U. Demkow, K. Popko, E. Gorska, R. Plywaczewski, A. Stoklosa, P. Sliwinski, M. Wasik, D. Gorecka (Warsaw, Poland)
| |
To investigate the ubiquitin-proteasome in obstructive sleep apnea/hopynea syndrome
Z. Huang, X. Gao, Q. Ou, S. Qing, C. Ye (Guangzhou, China)
| |
The oxidize stress of monocyte and the change of perforin in lymphocyte of CD8+T cell in patients with OSAHS
X. Gao, Z. Huang, Q. Ou, S. Qing, C. Ye (Guangzhou, China)
| |
The effect of CPAPn treatment in oxidative stress in patients with SAHS
C. Hernandez, J. Abreu, P. Abreu, A. Castro, A. Jimenez, C. Martin, C. Cabrera (La Laguna, Spain)
| |
Antioxidant status in obstructive sleep apnea: no influence of one night continuous airway pressure therapy
K. Katsoulis, D. Spanogiannis, O. Nikitidou, T. Kontakiotis, M. Kougioulis, S. Gerou, E. Daskalopoulou, M. Vlachogiannis (Thessaloniki, Greece)
| |